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Abstract
Peritoneal dialysis (PD) has attained increased relevance as continuous renal replacement
therapy over the past years. During this treatment, the peritoneum functions as dialysis
membrane to eliminate diffusible waste products from the blood-stream. Success and
efficacy of this treatment is dependent on the integrity of the peritoneal membrane.
Chronic inflammatory conditions within the peritoneal cavity coincide with elevated
levels of proinflammatory cytokines leading to the impairment of tissue integrity. High
glucose concentrations and glucose metabolites in PD solutions contribute to structural
and functional reorganization processes of the peritoneal membrane during long-term
PD. The subsequent loss of ultrafiltration is causal for the treatment failure over time.
It was shown that peritoneal mesothelial cells are functionally connected via Nanotubes
(NTs) and that a correlation of NT-occurrence and defined pathophysiological conditions
exists. Additionally, an important participation of NTs during inflammatory reactions
was shown. Here, we will summarize recent developments of NT-related research and
provide new insights into NT-mediated cellular interactions under physiological as well
as pathophysiological conditions.
Section
Peritoneal dialysis (PD) is an accepted alternative to hemodialysis in the treatment of
end-stage renal disease. However, when compared internationally, PD-treatment is still
underrepresented in Germany (Lameire and Van Biesen, 2010). In this treatment, the
peritoneal membrane functions as semipermeable membrane allowing for ultrafiltration
and diffusion (Krediet, 1999). In order to produce osmotically induced ultrafiltration, heat
sterilized glucose containing dialysis solutions are used to ensure hyperosmolarity. The heat
sterilization leads to the formation of glucose degradation products (GDPs) (Wieslander
et al., 1995) which mainly contribute to the formation of advanced glycation end-products
(AGEs) including methylglyoxal (MG) (Nakayama et al., 1997; Muller-Krebs et al., 2008).
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The implantation and presence of an indwelling catheter, high glucose concentrations, and
GDPs in the dialysis solutions as well as peritonitis - a known complication of PD - coincide
with high levels of proinflammatory cytokines within the peritoneal cavity and subsequent
induce chronic inflammatory conditions leading to structural and functional changes of the
peritoneal membrane (Witowski et al., 2000; Flessner et al., 2007, 2010).
Moreover, a strong induction of the expression of the receptor for advanced glycation end-
products (RAGE) in the peritoneal membrane of uremic patients was demonstrated which
further increased after PD treatment (Kihm et al., 2008), showing AGE-RAGE interactions
being crucial in peritoneal damage due to inflammatory conditions, uremia, and PD. The
resulting loss of ultrafiltration, as well as progressive fibrosis, angiogenesis, and vascular
degeneration limit long-term PD-treatment (Margetts and Churchill, 2002; Devuyst et al.,
2010).
It is now clear that peritoneal mesothelial cells, specialized epithelial cells that line the
peritoneal cavity, not only function as non-adhesive surface to facilitate intracoelomic
movement. These cells are crucial for the maintenance of peritoneal homeostasis, transport
processes across the peritoneal membrane and tissue repair (Mutsaers, 2004; Yung and
Chan, 2007). Furthermore, they provide defense against bacterial insult and are essentially
exposed to the bioincompatible dialysis solutions during PD-treatment. In response to
Tumor-Necrosis-Factor (TNF) and Interleukin-1 (IL-1) secreted by peritoneal macrophages,
peritoneal mesothelial cells synthesize various cytokines, including IL-1, IL-6, and IL-8,
thus enhance the inflammatory signal and recruit leukocytes in the peritoneal cavity
(Douvdevani et al., 1994; Topley, 1995; Li et al., 1998). In the immune system, peritoneal
mesothelial cells bear an effective antigen-presenting function for T cells and thereby play
a relevant role during the immune response in the peritoneal cavity e.g., during peritonitis
(Valle et al., 1995; Hausmann et al., 2000). However, with increasing PD-treatment,
peritoneal mesothelial cells undergo a progressive loss of their epithelial phenotype toward
a myofibroblast-like phenotype (Yanez-Mo et al., 2003). Thereby, a loss of characteristic
cell-cell junctions, apical-basal polarity as well as reorganization of the cytoskeleton
and reprogramming of the gene expression take place (Lamouille et al., 2014). This
differentiation process, known as epithelial-mesenchymal transition (EMT), reflects the
enormous plasticity of mesothelial cells (Yung and Chan, 2012).
In the context of inflammatory immune reactions, intercellular communication plays a
crucial role. In 2004, the discovery of Nanotubes (NTs) mediating membrane continuity
has extended the understanding of cell-to-cell communication (Rustom et al., 2004). These
NTs were initially characterized as thin intercellular membrane channels, formed between
cultivated pheochromocytoma (PC12) cells at their nearest distance and without contact
to the substratum (Figure 1A), displaying diameters from 50 to 200 nm and lengths of up
to several cell diameters (Rustom et al., 2004). NTs contain F-actin and/or microtubule
backbones and facilitate the intercellular transmission of various cellular components,
including organelles as well as plasma membrane constituents or the transfer of electric
signals (Hurtig et al., 2010; Wang et al., 2010; Wang and Gerdes, 2012). Meanwhile, NTs
have been found to be present in cultures of different cell types including for example
mesothelial (Figure 1B) and epithelial cells, fibroblasts, immune cells, and neurons
(Vidulescu et al., 2004; Castro et al., 2005; Watkins and Salter, 2005; Davis and Sowinski,
2008; Gerdes and Carvalho, 2008; Pontes et al., 2008; Ranzinger et al., 2011). Moreover,
recent research demonstrates the existence of NTs in human primary tumors (Lou et al.,
2012).
Figure 1
Schematic model of molecular mechanisms with implications for NT-mediated cellular
interactions during PD. (A) The cartoon depicts the principle of NT-formation and NT-
mediated transfer of organelles between cells. (B) The fluorescence microscopy picture
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shows NTs (arrows) spanned between primary human peritoneal mesothelial cells. (C)
Illustration of the interdependence of NT-formation and communication in the context of
PD-treatment including stimulating/inhibiting factors.
During the last 10 years, a lot of knowledge concerning formation, function, and biological
implications of NTs in health and disease has been gained. Aside from mediating functional
connectivity between various cell types, it is now clear that NTs participate in several
pathological processes of substantial medical interest. NTs were proposed to be involved
in the intercellular spread of prion proteins (Gousset and Zurzolo, 2009; Dunning et al.,
2012) and viral proteins, e.g., during HIV infections (Eugenin et al., 2009; Kadiu and
Gendelman, 2011; Sowinski et al., 2011), the transfer of drug resistance between cancer
cells (Pasquier et al., 2012) or the transfer of A# peptides in the context of Alzheimer's
disease (Wang et al., 2011). Moreover, it could be demonstrated that the number of NTs
in humans is dependent on the individual donor background (Ranzinger et al., 2011) and
correlates with defined pathophysiological conditions. In in vitro experiments, in which cells
were stimulated with TNF, the number of NTs is significantly increased and associated with
a remodeling of the actin cytoskeleton. This finding could be confirmed when NT-numbers
were investigated between cells from PD-patients (Ranzinger et al., 2011) pointing to an
important participation of NTs during inflammatory reactions.
Additionally, a strong correlation of NT occurrence with cellular cholesterol contents and
its distribution throughout the cell could be demonstrated. Experiments, in which cellular
cholesterol homeostasis in HPMCs was affected by cholesterol depletion via methyl-#-
cyclodextrin (M#Cyc), revealed that gradual cholesterol depletion results in a strong, non-
linear modulation of NT-numbers and lengths with significant peaks at given M#Cyc
concentrations, pointing to narrow windows of defined cholesterol contents being beneficial
or detrimental, e.g., by affecting NT tensile strength or by influencing the formation process
(Ranzinger et al., 2011). The finding that statin-treatment of HPMCs resulted in significantly
increased NT-numbers coincides with comparably high numbers of NTs found between
cells from a patient undergoing statin treatment (Ranzinger et al., 2013). In a recent study,
Thayanithy et al. (2014) explored exosomes and lipid rafts as mediators of NT-formation in
mesothelioma cells. Their results provide evidence for exosomes as chemotactic stimuli for
NT-formation and lipid raft formation as potential biomarker for NT-forming cells.
To date, aside from inflammatory conditions, several factors are known that lead to the
induction of NT-formation, among these oxidative stress as well as several receptor-ligand
interactions (Martinez et al., 2002; Zhu et al., 2005; Chinnery et al., 2008; Ranzinger et
al., 2011; Wang et al., 2011; Sun et al., 2012). In the context of PD-treatment, the use
of dialysis solutions lead to a significant reduction in NT-numbers between peritoneal
mesothelial cells (Ranzinger et al., 2011). Observed more closely, oxidative stress caused
by both methyglyoxal (MG) and acidified pH-value results in higher NT-numbers whereas
alterations in cellular osmolarity due to enhanced glucose concentrations lead to a strong
decrease in NT-numbers between the cells (Ranzinger et al., 2014). In this context, by
blocking of RAGE, whose expression is upregulated during PD-treatment, it could be shown
that this receptor is a strong regulator in NT-formation processes between murine and
human peritoneal mesothelial cells in vitro and in vivo (Ranzinger et al., 2014).
Respective underlying molecular mechanisms involved in the formation of NTs are
controversially discussed. Studies from Wang et al. (2011) showed that NT-formation in
primary rat hippocampal astrocytes and neurons is dependent on the activation of the tumor
suppressor protein p53 through hydrogen peroxide induced cellular stress. Andresen et al.
(2013) however showed that p53 is dispensable for NT-formation in SAOS-2 cells and
dKO-MSCs. The results of these studies demonstrate that signaling pathways and involved
proteins having an impact on the formation of NTs act strongly cell-type dependent.
A previous study from Zhu et al. (2005) showed that oxidative stress induced by H2O2
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increases the formation of NTs in astrocytes through activation of the p38 mitogen-activated
protein kinase (MAPK) pathway. In the context of RAGE being involved in the formation of
NTs between peritoneal mesothelial cells, the MAPK signaling cascade, which is addressed
upon RAGE activation, was investigated in a recent study from Ranzinger et al. (2014). It
could be demonstrated that oxidative stress induced by MG not only induces NT-formation
but also increases phosphorylated p38 protein levels. Subsequently, blocking of p38 resulted
in reduced NT-numbers between the cells arguing that the action of p38 regulates NT-
formation in peritoneal mesothelial cells.
The existence of NTs in vivo has been supported by an increasing number of publications
(Eugenin et al., 2009; Pyrgaki et al., 2010; Caneparo et al., 2011; Ranzinger et al.,
2014). However, their occurrence, architecture, and function in the body is still a matter
of considerable debate and may vary in accordance to the respective species, tissue,
developmental stage, age, genetic background, and pathophysiological variations.
One possible function could be a NT-mediated rescue for cells and/or organs under
pathophysiological conditions like oxidative stress (Figure 1C).
In this view, several studies showed e.g., the transfer of mitochondria via NTs (Koyanagi et
al., 2005; Domhan et al., 2011; Wang et al., 2011). A study from Vallabhaneni et al. (2012)
showed that vascular smooth muscle cells initiate proliferation of mesenchymal stem cells
through the exchange of mitochondria in co-cultures. Pasquier et al. (2013) demonstrated
that cancer cells acquiring mitochondria from endothelial cells display significant
chemoresistance. Furthermore, work from Spees et al. (2006) could demonstrate that aerobic
respiration in cells with dysfunctional mitochondria could be rescued by mitochondrial
transfer. More recently, concerning ischemia/reperfusion (I/R)-induced injury of the kidney,
in a RAGE knockout mouse model, it could be shown that under conditions where RAGE is
absent, NT-numbers are increased and kidney tissue morphology is improved compared to
kidneys from wild-type mice (Ranzinger et al., 2014). Interestingly, when RAGE is blocked
and dialysis solution as secondary stimulus has been applied, increased NT-numbers could
also be demonstrated in peritoneal mesothelial cells (Ranzinger et al., 2014). In these
cases, one could speculate that a protective effect for the respective organ/tissue might be
attributed to an increased NT-formation accompanied by frequent exchanges of for example
mitochondria.
In the future, further investigations are needed to investigate NT-mediated transport
mechanisms within the peritoneal cavity in greater detail. This will have significant impact
on the understanding of a variety of processes, such as inflammatory immune reactions.
Potentially, this knowledge will allow for the development of improved treatment options
during peritoneal infection.
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